Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice
- PMID: 18305141
- DOI: 10.2337/db07-1403
Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice
Abstract
Objective: Diabetes and obesity are characterized by a low-grade inflammation whose molecular origin is unknown. We previously determined, first, that metabolic endotoxemia controls the inflammatory tone, body weight gain, and diabetes, and second, that high-fat feeding modulates gut microbiota and the plasma concentration of lipopolysaccharide (LPS), i.e., metabolic endotoxemia. Therefore, it remained to demonstrate whether changes in gut microbiota control the occurrence of metabolic diseases.
Research design and methods: We changed gut microbiota by means of antibiotic treatment to demonstrate, first, that changes in gut microbiota could be responsible for the control of metabolic endotoxemia, the low-grade inflammation, obesity, and type 2 diabetes and, second, to provide some mechanisms responsible for such effect.
Results: We found that changes of gut microbiota induced by an antibiotic treatment reduced metabolic endotoxemia and the cecal content of LPS in both high-fat-fed and ob/ob mice. This effect was correlated with reduced glucose intolerance, body weight gain, fat mass development, lower inflammation, oxidative stress, and macrophage infiltration marker mRNA expression in visceral adipose tissue. Importantly, high-fat feeding strongly increased intestinal permeability and reduced the expression of genes coding for proteins of the tight junctions. Furthermore, the absence of CD14 in ob/ob CD14(-)(/)(-) mutant mice mimicked the metabolic and inflammatory effects of antibiotics.
Conclusions: This new finding demonstrates that changes in gut microbiota controls metabolic endotoxemia, inflammation, and associated disorders by a mechanism that could increase intestinal permeability. It would thus be useful to develop strategies for changing gut microbiota to control, intestinal permeability, metabolic endotoxemia, and associated disorders.
Similar articles
-
Metabolic endotoxemia initiates obesity and insulin resistance.Diabetes. 2007 Jul;56(7):1761-72. doi: 10.2337/db06-1491. Epub 2007 Apr 24. Diabetes. 2007. PMID: 17456850
-
Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice.FASEB J. 2008 Jul;22(7):2416-26. doi: 10.1096/fj.07-102723. Epub 2008 Mar 7. FASEB J. 2008. PMID: 18326786
-
Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability.Gut. 2009 Aug;58(8):1091-103. doi: 10.1136/gut.2008.165886. Epub 2009 Feb 24. Gut. 2009. PMID: 19240062 Free PMC article.
-
Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.JPEN J Parenter Enteral Nutr. 2011 Sep;35(5 Suppl):14S-20S. doi: 10.1177/0148607111413772. Epub 2011 Aug 1. JPEN J Parenter Enteral Nutr. 2011. PMID: 21807932 Review.
-
Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding.Pathol Biol (Paris). 2008 Jul;56(5):305-9. doi: 10.1016/j.patbio.2007.09.008. Epub 2008 Jan 30. Pathol Biol (Paris). 2008. PMID: 18178333 Review.
Cited by
-
Gut microbiota composition and type 2 diabetes: Are these subjects linked Together?Heliyon. 2024 Oct 16;10(20):e39464. doi: 10.1016/j.heliyon.2024.e39464. eCollection 2024 Oct 30. Heliyon. 2024. PMID: 39469674 Free PMC article.
-
Harnessing Prebiotics to Improve Type 2 Diabetes Outcomes.Nutrients. 2024 Oct 11;16(20):3447. doi: 10.3390/nu16203447. Nutrients. 2024. PMID: 39458444 Free PMC article. Review.
-
A Novel Bifidobacterium longum Subsp. longum T1 Strain from Cow's Milk: Homeostatic and Antibacterial Activity against ESBL-Producing Escherichia coli.Antibiotics (Basel). 2024 Sep 27;13(10):924. doi: 10.3390/antibiotics13100924. Antibiotics (Basel). 2024. PMID: 39452191 Free PMC article.
-
Gut microbial metabolic signatures in diabetes mellitus and potential preventive and therapeutic applications.Gut Microbes. 2024 Jan-Dec;16(1):2401654. doi: 10.1080/19490976.2024.2401654. Epub 2024 Oct 18. Gut Microbes. 2024. PMID: 39420751 Free PMC article. Review.
-
Inflammaging and Brain Aging.Int J Mol Sci. 2024 Sep 30;25(19):10535. doi: 10.3390/ijms251910535. Int J Mol Sci. 2024. PMID: 39408862 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous